Bioinova Quality Policy

The priority of Bioinova is:

To bring patients innovative, accessible, and effective treatment methods across various fields of regenerative medicine and diagnostics. We strive to achieve this by combining pioneering ideas, high-tech equipment, hard work, and strong partnerships.

Our goal is:

To respond flexibly to scientific progress and, in the long term, to set the direction in the field of tissue regeneration, biomedical engineering, and diagnostics.

Within the laboratory activities of the Department of Molecular Diagnostics:

• No influence by company management on the course or outcomes of laboratory testing.
• Authority delegated to the Head of Laboratory to refuse any laboratory examinations that could compromise the independence or credibility of the laboratory.

Towards our clients, suppliers, business partners, the public, and regulatory authorities, we commit to:

• Building and continuously improving a quality management system in accordance with ISO 9001, ISO 13485, and ISO 15189, with a strong focus on setting clear process objectives and enhancing client satisfaction.
• Complying with the principles of Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Distribution Practice (GDP).
• Closely monitoring and adhering to all applicable legal requirements, including laws, regulations, directives, and standards.
• Providing regular education and training for our employees, as their professionalism and dedication are key to the company’s success.
• Selecting qualified and trusted suppliers, enabling us to deliver high-quality products that meet legislative requirements and the standards of ISO 9001, ISO 13485, and ISO 15189.